|
Market Closed -
Other stock markets
|
After hours 08:00:00 pm | |||
| 15.00 USD | -0.73% |
|
71.69 | +377.93% |
| Jun. 08 | Sarepta Therapeutics, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 10:40 AM | |
| Jun. 04 | Sarepta Therapeutics, Inc. - Shareholder/Analyst Call |
| Market Cap | 1.58B 1.37B 1.27B 1.19B 2.22B 152B 2.26B 15.11B 5.85B 73.09B 5.94B 5.82B 254B | P/E Ratio 2026 * |
4.23x | P/E Ratio 2027 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.07B 931M 858M 804M 1.5B 103B 1.53B 10.24B 3.96B 49.52B 4.03B 3.94B 172B | EV / Sales 2026 * |
0.58x | EV / Sales 2027 * | 0.46x |
| Free-Float |
95.19% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Sarepta Therapeutics, Inc.
| 1 day | -0.73% | ||
| 1 week | -9.96% | ||
| Current month | -16.06% | ||
| 1 month | -22.68% | ||
| 3 months | -14.65% | ||
| 6 months | -31.03% | ||
| Current year | -30.30% |
| 1 week | 14.68 |  | 16.28 |
| 1 month | 14.68 | | 19.42 |
| Current year | 14.68 | | 24.68 |
| 1 year | 10.42 | | 38.09 |
| 3 years | 10.42 | | 173.25 |
| 5 years | 10.42 | | 173.25 |
| 10 years | 10.42 | | 181.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
Douglas Ingram
CEO | Chief Executive Officer | 63 | 2017-06-25 |
Ryan Wong
DFI | Director of Finance/CFO | 47 | 2025-07-15 |
Ian Estepan
DFI | Director of Finance/CFO | 50 | 2020-12-13 |
| Director | Title | Age | Since |
|---|---|---|---|
M. Wilsey
CHM | Chairman | 73 | 2015-04-15 |
| Director/Board Member | 87 | 2010-05-31 | |
Richard Barry
BRD | Director/Board Member | 67 | 2015-06-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Jun. 03 | Free | Director | 16,875 | 0.0160% | ||
| Jun. 03 | Free | Director | 16,875 | 0.0160% | ||
| Jun. 03 | Free | Director | 16,875 | 0.0160% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.73% | -9.96% | -60.33% | -88.25% | 1.58B | |
| +4.40% | +2.87% | -36.07% | -53.33% | 2.35B | |
| +1.91% | +2.01% | -10.09% | -11.74% | 318M | |
| +4.82% | -2.25% | -38.72% | - | 59.05M | |
| Average | +2.60% | -0.96% | -36.30% | -51.11% | 1.08B | |
| Weighted average by Cap. | +2.34% | -1.89% | -43.09% | -63.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.84B 1.6B 1.47B 1.38B 2.57B 176B 2.63B 17.54B 6.79B 84.83B 6.9B 6.75B 295B | 1.42B 1.24B 1.14B 1.07B 1.99B 136B 2.04B 13.59B 5.26B 65.72B 5.35B 5.23B 229B |
| Net income | 415M 360M 332M 311M 581M 39.75B 593M 3.96B 1.53B 19.16B 1.56B 1.52B 66.62B | 91.18M 79.13M 72.94M 68.34M 128M 8.73B 130M 870M 337M 4.21B 342M 335M 14.63B |
| Net Debt | -511M -443M -409M -383M -715M -48.91B -730M -4.87B -1.89B -23.58B -1.92B -1.88B -81.97B | -928M -806M -743M -696M -1.3B -88.89B -1.33B -8.86B -3.43B -42.85B -3.49B -3.41B -149B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-11 | 15.00 $ | -0.73% | 2,758,816 |
| 26-06-10 | 15.11 $ | -4.91% | 2,332,214 |
| 26-06-09 | 15.89 $ | +2.19% | 2,437,071 |
| 26-06-08 | 15.55 $ | -1.27% | 2,426,430 |
| 26-06-05 | 15.75 $ | -5.46% | 2,739,948 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SRPT Stock
Select your edition
All financial news and data tailored to specific country editions
